36 leading biopharmaceutical companies now participate in this unique global modeling and simulation research group PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin Co., Ltd. has joined the Simcyp Consortium and licensed the Simcyp® Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company […]
OAKLAND, Calif. & SAN FRANCISCO, Calif.–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing examination of its patients’ genomic data to augment data […]
vermicon AG and Sysmex Europe GmbH agree on partnership for product distribution MUNICH Sysmex Europe GmbH, a subsidiary of the international enterprise Sysmex Corporation, andvermicon AG, hereby announce the start of a business partnership. The first result of this alliance, a combination of flow cytometry and gene probe technology known as the ‘Flow VIT® Solution’ detection system, will provide highly sensitive and sector-specific solutions for industrial microbiology with the aim of raising quality control to a new level. For almost 50 years, Sysmex Partec GmbH, a subsidiary of the Sysmex […]
SAN DIEGO – Edico Genome today announced the commercial deployment of its DRAGENTM Bio-IT Platform on Amazon Web Services (AWS) Marketplace, enabled by the recent general availability of the Amazon Elastic Compute Cloud (Amazon EC2) F1 instance type. Amazon EC2 F1 instances are powered by Xilinx Virtex UltraScale+ field programmable gate arrays (FPGAs) and are designed to provide capabilities for […]
Advanced Analytical Technologies, Inc (AATI) is excited to partner with Illumina to support collaborations and co-marketing activities involving our Fragment Analyzer™ Automated CE Systems for quality assessment of nucleic acids in Illumina next-generation sequencing (NGS) workflows. Assessing nucleic acid quality is essential for the success of NGS applications. The Fragment Analyzer provides a scalable method, tested by Illumina, for […]
Beacon™ OptoFluidic Platform to Automate Workflows for Greater Efficiencies Emeryville, CA – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, today announced a strategic project with Bayer AG, Germany (Bayer), focused on the innovation and acceleration of cell line development, antibody discovery, and research. As part of the […]
Distribution Agreement with Aspect Imaging adds NMR Spectroscopy and Rheology MRI Instruments to Quantum Analytics’ industrial product portfolio. Foster City, California – Quantum Analytics is excited to announce that it has entered into an Exclusive Distribution Agreement with Aspect Imaging, a developer of compact magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) systems for […]
Illumina Partners with Advanced Analytical Technologies to Deliver Scalable Quality Assessment Solutions September 12, 2017 Advanced Analytical Technologies, Inc. (AATI) and Illumina recently entered into an agreement to support collaborations and co-marketing activities involving AATI’s Fragment Analyzer™ Automated CE Systems for quality control (QC) analysis of nucleic acids in Illumina next-generation sequencing (NGS) workflows. The Fragment Analyzer accelerates […]
– 10x Genomics’ Chromium™ de novo Assembly Solution Adopted to Generate High Quality Reference Genome Assemblies using Linked-Reads Data – PLEASANTON, Calif.—10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, announced today that the pioneering Chromium™ de novoAssembly Solution will be used for the generation of high-quality genome assemblies to capture the […]
Newswise — Wilmington, DE – To accelerate the development of next-generation cancer therapies, the Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System has agreed to provide genetically modified cell lines to Analytical Biological Services, Inc. (ABS) of Wilmington, Delaware. Under a three-year agreement, the Gene Editing Institute will act as sole […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
